HALO AP Dx

Leica Biosystem and Indica Labs combined Aperio HALO AP DX and Aperio GT 450 DX Scanner for a complete clinical digital pathology ecosystem

Leica Biosystems and Indica Labs Expand Digital Pathology-Powered Diagnostics in the USA with Aperio HALO AP DX Software Launch

HALO AP, HALO AP Dx, News, Press Releases / , , ,

Vista, CA, and Albuquerque, NM, March 31, 2026 – Leica Biosystems, a Danaher company and a global leader in anatomic and digital pathology solutions, and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, launches Aperio HALO AP DX image management system designed for use with the Aperio GT 450 DX scanner. Together, the Aperio HALO AP DX software and the Aperio GT 450 DX scanner provide a complete, integrated clinical digital pathology solution supporting on‑screen diagnostics across routine pathology workflows in the USA.

Leica Biosystems and Indica Labs Expand Digital Pathology-Powered Diagnostics in the USA with Aperio HALO AP DX Software Launch Read More »

A lap top looking over the Sandia mountains in Albuquerque, NM; showcasing an IHC breast tissue image on the lap top screen with HER2 3+ stanning. Using AI and digital pathology for precision medicine, anytime anywhere.

AI and Digital Pathology in Personalized Medicine: The Past, Present, and Future of Breast Cancer Care

Blogs, Breast IHC AI, HALO AP, News / , , , , ,

AI-powered digital pathology is redefining modern cancer care by extending clinical-grade insights beyond the microscope and enabling standardized, pixel-level analysis to support scalable cancer diagnostics anytime, anywhere.

AI and Digital Pathology in Personalized Medicine: The Past, Present, and Future of Breast Cancer Care Read More »

Global map where Indica Labs has deployments

Indica Labs Surpasses 3,000 Deployments of HALO Digital Pathology Software Worldwide Since 2013

HALO, HALO AI, HALO AP, HALO AP Dx, HALO Clinical AI, HALO Link, HALO Modules, News, Press Releases / , , , , , ,

Albuquerque, NM, March 3, 2026 – Indica Labs, the global leader in AI-powered digital pathology software and services, today announces surpassing the 3,000th installation of HALO software worldwide.

Indica Labs Surpasses 3,000 Deployments of HALO Digital Pathology Software Worldwide Since 2013 Read More »

Looking Back: Reviewing 2025 at Indica Labs

Blogs, Breast IHC AI, Cloud Services, CRC Macrodissect AI, HALO, HALO AI, HALO AI Apps, HALO AP, HALO AP Dx, HALO Clinical AI, HALO Link, Lung Macrodissect AI, News, Pharma Services, SlideQC BF / , , , , , , , , , ,

As we reach the end of 2025, the Indica Labs team extends our sincere thanks to the customers and collaborators who helped make this year one of remarkable innovation, growth, and scientific achievement.

Looking Back: Reviewing 2025 at Indica Labs Read More »

The rapid global adoption of HALO AP® prompted immediate localization of the platform in Chinese, Danish, Dutch, American and British English, Finnish, French, German, Greek, Italian, Norwegian, Japanese, Portuguese, Russian, Spanish, Slovakian, and Swedish. Shown here are all 17 languages represented as each country's flags.

Indica Labs Reports 260% Clinical Revenue Growth and Expansion into New Global Markets

Breast IHC AI, HALO AP, HALO AP Dx, HALO Clinical AI, HALO Macrodissect Solutions, Lung Macrodissect AI, News, Press Releases / , , , , , , , ,

Albuquerque, NM, December 17, 2025 – Indica Labs, the global leader in AI-powered digital pathology, announced today that clinical revenue growth rate for HALO AP® is up 260% since 2023 and recurring revenue for 2025 shows a 200% increase year-over-year, reinforcing its position as a market leader in digital pathology diagnostics.

Indica Labs Reports 260% Clinical Revenue Growth and Expansion into New Global Markets Read More »

Indica Labs, HALO AP Dx, FDA 510(k)-cleared digital pathology platform displayed with the Aperio GT 450 DX Scanner for in vitro diagnostic use.

Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems

Clinical, HALO AP, HALO AP Dx, News, Press Releases / , ,

ALBUQUERQUE, NM, and VISTA, CA, December 3, 2025 – Indica Labs, the global leader of AI-powered digital pathology, and Leica Biosystems, a global leader in anatomic and digital pathology solutions, announced today that the Food and Drug Administration (FDA) has issued a 510(k) clearance for the enterprise digital pathology platform HALO AP Dx in conjunction with Leica Biosystems Aperio GT 450 DX Scanner for in-vitro diagnostic use.

Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems Read More »

Free Demo
Free Demo
Scroll to Top